Form D · Other Health Care
Galatea Bio, Inc.
Miami Lakes, FL · CIK 0002036550
Offering snapshot reported Sep 6, 2024 · SEC filing
- Reported sold
- $3.66M Offering amount: $12M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Aug 23, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 6, 2024 | Initial | $3,656,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-523375
Source: Form D, filed Sep 6, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Wale Ayeni | Director |
| Carlos D. Bustamante | Director, Executive |
| Cindy Cheung | Director |
| Alexander Ioannidis | Director |
| Nicholas Katsanis | Director |
| Mohit Kaushal | Director |
| Muzammil Mansuri | Director |
| Arthur Polk | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
14350 Commerce Way
Miami Lakes, FL, 33016
Miami Lakes, FL, 33016